Breaking News
December 13, 2018 - Long-term Benefit of Steroid Injections for Knee Osteoarthritis Challenged
December 13, 2018 - Adding new channels to the brain remote control
December 13, 2018 - In the Spotlight: A different side of neuroscience
December 13, 2018 - Medical Marvels: Using immunotherapy for melanoma that spread to the brain
December 13, 2018 - Puzzles do not keep dementia away finds study
December 13, 2018 - New mouse model shows potential for rapid identification of promising muscular dystrophy therapies
December 13, 2018 - Study reveals urban and rural differences in prenatal exposure to essential and toxic elements
December 13, 2018 - New collaborative partnership in quest of novel antibiotics
December 13, 2018 - Single tau molecule holds clues to help diagnose neurodegeneration in its earliest stages
December 13, 2018 - AHA Scientific Statement: Low Risk of Side Effects for Statins
December 13, 2018 - What Is Acute Flaccid Myelitis?
December 13, 2018 - How bereaved people control their thoughts without knowing it
December 13, 2018 - Health care democratization underway, according to 2nd annual Stanford Medicine Health Trends Report | News Center
December 13, 2018 - Going Beyond a Single Color
December 13, 2018 - London-based startup launches ‘’ aiming to clean up CBD industry
December 13, 2018 - Loss of tight junction barrier protein results in gastric cancer development
December 13, 2018 - Novel way to efficiently deliver anti-parasitic medicines
December 13, 2018 - RKI publishes new data on disease prevention and utilization of medical services
December 13, 2018 - High-tech, flexible patches sewn into clothes could help to stay warm
December 13, 2018 - Restoring Hair Growth on Scarred Skin? Mouse Study Could Show the Way
December 13, 2018 - Probiotic use may reduce antibiotic prescriptions, researchers say
December 13, 2018 - Drug repositioning strategy identifies potential new treatments for epilepsy
December 13, 2018 - Chronic rhinitis associated with hospital readmissions for asthma and COPD patients
December 13, 2018 - Food poisoning discovery could save lives
December 13, 2018 - Cloned antibodies show potential to treat, diagnose life-threatening fungal infections
December 13, 2018 - Exercise may reduce colorectal cancer risk after weight loss
December 13, 2018 - Russian scientists create hardware-information system for brain disorders treatment
December 13, 2018 - Moderate alcohol consumption linked with lower risk of hospitalization
December 13, 2018 - Nurturing Healthy Neighborhoods | NIH News in Health
December 13, 2018 - Rise in meth and opioid use during pregnancy
December 13, 2018 - Researchers gain new insights into pediatric tumors
December 13, 2018 - FSU study finds racial disparity among adolescents receiving flu vaccine
December 13, 2018 - Study investigates attitudes toward implementation of ‘sex as a biological variable’ policy
December 13, 2018 - Drug cocktail induces cancer cell death by switching off energy supply
December 13, 2018 - Baculovirus virion completely eliminates liver-stage parasites in mouse model
December 13, 2018 - Researchers create noninvasive technology that detects when nerve cells fire
December 13, 2018 - Allen Institute for Immunology to partner with CU Anschutz to understand dynamics of human immune system
December 13, 2018 - Inability to do daily living tasks delays discharge of mental health patients
December 13, 2018 - Treating patients with hypertension induced albuminuria
December 13, 2018 - New substance could improve efficacy of established breast cancer treatments
December 13, 2018 - Scientists develop new stem cell line to study conversion of stem cells into muscle
December 13, 2018 - Re-programming the body’s energy pathway boosts kidney self-repair
December 13, 2018 - Research findings could help improve treatment of anxiety and post-traumatic stress disorders
December 13, 2018 - The Microbiome Movement announce Microbiotica as official industry partner
December 13, 2018 - New study reveals potential benefits of cEEG monitoring for infant ICU patients
December 13, 2018 - Whole-body imaging PET/MRI offers information to guide treatment options for prostate cancer
December 13, 2018 - International investigators fight against the negative campaign on benzodiazepines
December 13, 2018 - Targeting biochemical pathway may lead to new therapies for alleviating symptoms of anxiety disorders
December 13, 2018 - FDA Approves Tolsura (SUBA®-itraconazole capsules) for the Treatment of Certain Fungal Infections
December 13, 2018 - Are scientists studying the wrong kind of mice?
December 13, 2018 - Computer memory: A scientific team builds a virtual model of a key brain region
December 13, 2018 - Visual inspection alone is insufficient to diagnose skin cancer
December 13, 2018 - Paternal grandfather’s access to food associated with grandson’s mortality risk
December 13, 2018 - Our brain senses angry voices in a flash, study shows
December 13, 2018 - PM2.5 Exposure Linked to Asthma Rescue Medication Use
December 13, 2018 - Can’t exercise? A hot bath may help improve inflammation, metabolism, study suggests
December 13, 2018 - Can artificial intelligence help doctors with the human side of medicine?
December 13, 2018 - Virginia Tech and UC San Diego researchers team up to develop nonopioid drug for chronic pain
December 13, 2018 - NIH offers support for HIV care and prevention research in the southern United States
December 12, 2018 - Activating brain region could revive the urge to socialize among opioid addicts
December 12, 2018 - Relationship impairment appears to interfere with seeking mental health treatment in men
December 12, 2018 - Sleep, Don’t Cram, Before Finals for Better Grades
December 12, 2018 - Effective treatments for urticarial vasculitis
December 12, 2018 - Gun violence is a public health issue: One physician’s story
December 12, 2018 - The Science of Healthy Aging
December 12, 2018 - Yes to yoghurt and cheese: New improved Mediterranean diet
December 12, 2018 - Researchers uncover a number of previously unknown insecticide resistance mechanisms
December 12, 2018 - Regulating the immune system’s ‘regulator’
December 12, 2018 - In breaking bad news, the comfort of silence
December 12, 2018 - Study finds upward link between alcohol consumption and physical activity in college students
December 12, 2018 - FDA issues warning letter to Zhejiang Huahai Pharmaceutical involved in valsartan recall
December 12, 2018 - Weight history at ages 20 and 40 could help predict patients’ future risk of heart failure
December 12, 2018 - Presence of antiphospholipid antibodies tied to first-time MI
December 12, 2018 - DNA analysis finds that stethoscopes are teaming with bacteria
December 12, 2018 - New study could help inform research on preventing falls
December 12, 2018 - Women and men with heart attack symptoms receive different care from EMS
December 12, 2018 - Disrupted biological clock can contribute to onset of diseases, USC study shows
December 12, 2018 - New publications generate controversy over the value of reducing salt consumption in populations
December 12, 2018 - New data from TAILORx trial confirms lack of chemo benefit regardless of race or ethnicity
December 12, 2018 - Specific class of biomarkers can accurately indicate the severity of cancer
Columbia Opioid Symposium Calls for Research, Action

Columbia Opioid Symposium Calls for Research, Action

image_pdfDownload PDFimage_print

Speakers at an opioid symposium sponsored by the Irving Institute for Clinical and Translational Research are, from left, Harold Pincus, MD; Mary Bassett, MD, MPH; Carlos Blanco, MD, PhD; Mark Olfson, MD, MPH; and Frances Levin, MD. (Photo credit: Chris Leary Photography)

Speakers at an opioid symposium this summer at Columbia University Irving Medical Center challenged participants to reverse the crisis’s grim statistics. In the U.S., opioid overdose deaths have nearly quadrupled since 1999 to more than 64,000 per year, and they account for 20 percent of deaths in young adults. Yet according to the Department of Health and Human Services, just 20 percent of individuals with an opioid use disorder receive any kind of treatment.

Reducing opioid use and overdoses will take more research, most speakers emphasized. Already at Columbia and NewYork-Presbyterian Hospital, such work is getting underway. An opioid brainstorm session was convened late last year to foster collaboration among researchers at Columbia, NewYork-Presbyterian Hospital, industry partners, and the community—and led to the formation of working groups focused on prescribing and pain management, addiction treatment, community engagement, and bench-to-bedside research on pain and addiction. (The session was organized by Columbia’s NIH Clinical and Translational Science Award Program and overseen by the Irving Institute for Clinical and Translational Research, a partnership between Columbia and NewYork-Presbyterian.) The meeting coincided with other initiatives—including NewYork-Presbyterian Hospital’s efforts to monitor and alter opioid prescribing and to increase community-based treatment of addiction.

“With these groups, we’re hoping to spark new ideas and new collaborations about how to address the opioid epidemic,” said Muredach Reilly, MBBCh, MSCE, director of the Irving Institute, Herbert and Florence Irving Professor of Medicine at Columbia University Vagelos College of Physicians and Surgeons (VP&S), and an attending physician at NewYork-Presbyterian Hospital.

“We need research and solutions to address the many narratives underlying this crisis—overmedication of chronic pain, undertreatment of opioid use disorder, and systemic medical system, societal, and legal failures—in order to stop people from dying.”

The symposium coincided with the recent launch of the NIH’s HEAL initiative, a $500 million research program to fund interdisciplinary research on addiction and pain.

The participants discussed current approaches toward preventing opioid use disorder and overdose—and how to improve those approaches. Carlos Blanco, MD, PhD, director of epidemiology, services, and prevention research at the National Institute on Drug Abuse, said prevention needs to be a priority, not an afterthought. To do that, he said, more research about who is at risk is needed.

Patients who appear to be most at risk of death from opioid overdose and related problems are those being treated for chronic pain, according to research from Mark Olfson, MD, MPH, professor of psychiatry at VP&S. “Many of these deaths occurred in people who had been prescribed opioids in combination with benzodiazepines in the final month of life, showing us that we have a fair amount of work to do to improve the safety of pain management,” he said.

“We have a fair amount of work to do to improve the safety of pain management,” said Mark Olfson, MD, MPH. (Photo credit: Chris Leary Photography)

The crisis also has affected its victims in other ways that we are just beginning to understand. “A great deal of attention has been placed on the risk of overdose deaths following nonfatal overdoses, but our latest study showed that individuals who survive a nonfatal overdose are also at increased risk of dying from a number of medical conditions, including circulatory and respiratory diseases, suicide, and HIV,” said Olfson.

We need to be more aggressive about using MAT, which will involve overcoming numerous barriers.

For individuals with opioid use disorder, proven treatments are available but underused. Medication addiction therapy (MAT)—including naltrexone, buprenorphine, and methadone—reduces the risk of relapse, overdose, and mortality, said Frances Levin, MD, the Kennedy-Leavy Professor of Psychiatry at VP&S and chief of the Division on Substance Use Disorders at Columbia University Irving Medical Center/New York State Psychiatric Institute. But out of the 20 percent of individuals with opioid use disorder who get treatment, less than a third are treated with MAT. “We need to be more aggressive about using MAT, which will involve overcoming numerous barriers to using and prescribing these medications,” said Levin, who also is a psychiatrist at NewYork-Presbyterian.

MAT medications are often hard to access outside of major metropolitan areas, explaining one barrier. Patients also must remain abstinent for a week before one of the medications (naltrexone) can be used. To remedy these problems, Levin said that faculty at Columbia are working to expand implementation of MAT in community-based settings and to improve naltrexone induction. Other treatments, including opioid vaccines, game-based interventions, and phrenic nerve stimulation to reverse overdose, are also being developed.

Rural America garners much of the media attention on the opioid epidemic, but cities are also affected. Since the introduction of fentanyl to the New York City market a few years ago, someone in our city dies of an opioid overdose every seven hours, said Mary Bassett, MD, MPH, commissioner of the New York City Department of Health and Mental Hygiene.

Slide from NYC Department of Health and Mental Hygiene

New York City has been tackling the opioid crisis on a variety of fronts. Mayor DeBlasio committed $60 million to train 1,500 providers in MAT prescription, open syringe exchange sites in areas most affected by overdose deaths, and develop media campaigns to destigmatize addiction treatment. The investment also will expand the city’s Relay overdose response system, which positions wellness advocates in hospital emergency rooms to guide overdose survivors toward treatment. Bassett also reported that, following a directive from the mayor’s office, 960 pharmacies now offer naloxone, which reverses opioid overdose, without a prescription.

The symposium ended with two concurrent sessions and panel discussions. One session, led by Beatrice Ellerin, director of the Healthcare and Pharmaceutical Management Program at the Columbia Business School, focused on the industry response to the crisis; another, led by the Community Engagement Core Resource of the Irving Institute with NewYork-Presbyterian Hospital, Columbia School of Social Work, and the Washington Heights Corner Project, focused on community responses to the crisis.

In the months ahead, the Irving Institute and partners will continue to challenge and engage researchers, government, and industry and community leaders in tackling the opioid crisis through research and action. “By sparking new ideas and new collaborations, providing seed funding for initial steps, and empowering our working groups to respond to the NIH Heal Initiative and other funding opportunities, we will continue to work with our partners to facilitate research and implementation of science-based solutions to address the many facets of this national crisis,” concluded Reilly.

Tagged with:

About author

Related Articles